Consolidated Statements of Income (USD $) In Millions, except Per Share data	3 Months Ended		9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010
Net Sales	$ 15,109	$ 12,868	$ 45,888	$ 39,903
Cost of sales	12,928	10,841	38,596	33,962
Research and development expenses	402	403	1,213	1,217
Selling, general and administrative expenses	691	640	2,086	1,950
Amortization of intangibles	125	124	373	377
Restructuring charges	0	0	0	29
Acquisition and integration related expenses	0	35	31	98
Equity in earnings of nonconsolidated affiliates	375	251	964	799
Sundry income (expense) - net	47	(10)	(322)	168
Interest income	9	7	26	24
Interest expense and amortization of debt discount	305	362	1,010	1,105
Income Before Income Taxes	1,089	711	3,247	2,156
Provision for income taxes	186	114	546	348
Net Income	903	597	2,701	1,808
Net income attributable to noncontrolling interests	3	0	24	9
Net Income attributable to The Dow Chemical Company	900	597	2,677	1,799
Preferred stock dividends	85	85	255	255
Net Income Available for The Dow Chemical Company Common Stockholders	815	512	2,422	1,544
Per Common Share Data:
Earnings per common share - basic	$ 0.70	$ 0.45	$ 2.08	$ 1.37
Earnings per common share - diluted	$ 0.69	$ 0.45	$ 2.07	$ 1.35
Common stock dividends declared per share of common stock	$ 0.25	$ 0.15	$ 0.65	$ 0.45
Weighted-average common shares outstanding - basic	1,152.3	1,128.0	1,147.2	1,123.6
Weighted-average common shares outstanding - diluted	1,160.9	1,145.5	1,157.8	1,140.7
Depreciation	539	555	1,624	1,717
Capital Expenditures	$ 651	$ 497	$ 1,620	$ 1,188